# OnCo record clarinet (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/clarinet/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "clarinet", "NCT00353496" ;
  schema:name "CLARINET"@en ;
  schema:description "Lanreotide more than halved the risk of progression in gut and pancreatic neuroendocrine tumours."@en ;
  schema:url <https://onco.cc/trials/clarinet/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00353496> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2006-06" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/small-intestinal-net/>, <https://onco.cc/cancers/pancreatic-net/> ;
  onco:drugs <https://onco.cc/drugs/octreotide-lanreotide/> ;
  onco:companies <https://onco.cc/companies/ipsen/> ;
  onco:people <https://onco.cc/people/martyn-caplin/> .
